Top Stories

Curated By Isabella Tang

By Isabella Tang 2026-06-16

Akeso Enrolls First Patient in Innovative Breast Cancer Study with HER3 ADC AK138D1 and Ivonescimab

Akeso has announced the enrollment of the first patient in a Phase Ib/II clinical trial evaluating its next-generation HER3 antibody-drug conjugate AK138D1 in combination with Ivonescimab for breast cancer treatment. This study represents a significant advancement in the company's IO2.0 + ADC2.0 strategy, aiming to improve therapeutic outcomes for patients.

By Isabella Tang 2026-06-16

Dollar Hits 10-Day Low as US-Iran Peace Deal Emerges

The US dollar has dropped to a 10-day low following a significant peace agreement between the United States and Iran. This development is expected to have far-reaching implications for international markets and geopolitical dynamics.